That is necessary, since the way a protein in the body folds identifies if a pharmaceutical will be able to bind to that protein and work. Simply put, we need to know how these proteins fold if we desire a drug to work. Historically, this has actually been an experimental procedure (future report). Today, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're designed to do. This was a development almost nobody noticed. But it's going to have profound ramifications for curing disease. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, obviously, there will be lots of investment opportunities in this space, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (longtime readers). That stated, I still believe bitcoin will continue to be unstable. We're close to all-time highs. I wouldn't be shocked if it drew back possibly substantially prior to going higher - first lady. I've been covering bitcoin for a very long time now. One of the first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I titled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were primarily educating readers. However that's not the big concern anymore. Now we're seeing institutional money lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a trusted 170-year-old organization. So think of that. In five years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
And that's a big factor I'm bullish on it this year. jeff brown biotech picks. Regards, Jeff Brown, Editor, The Bleeding Edge I have a benefit forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than 20 years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are many excellent private business on the edge of hitting the general public markets And I've been dealing with a brand-new way for you to invest even before these business go public.
This chance has been building over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to discover all the information. Go right here to reserve your area totally free.
Emma Walsh here, handling editor of the Diary. Regular Journal readers understand that tech isn't our typical beat (jeff bezos). And when it concerns tech investing, we leave it to the experts. Luckily, we have a number of such professionals in our Rolodex. Our colleague Jeff Brown will recognize to our long time readers. He is one of the most accomplished tech investing professionals we understand (jeff brown biotech stock). In truth, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big photo and anticipate what's simply around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and far more. These trends are experiencing exponential development and developing extraordinary opportunities for investors. I want to make sure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a topic I've been covering for years now. jeff bezos. But in spite of what many readers may think, this is a trend that's just getting started. Despite the fact that the COVID-19 pandemic interfered with supply chains last year, an outstanding 250 million 5G-enabled gadgets were still sold.
And all of this eventually resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (jeff brown stock predictions). Losing 2 months of production and sales really impacts how numerous 5G devices are sold in the fiscal year. When you consider all of that, selling 250 million units is exceptional. More notably, the delays brought on by the pandemic created a load of bottled-up need. And that need is now going to be pushed into 2021. In truth, I forecast that more than 500 million 5G gadgets will be shipped in 2021 - legacy report prediction. And that's not my only 5G prediction When I have actually discussed 5G in the past, I have actually explained its 3 different stages.
In Stage Two, 5G gadgets go on sale. 5G phones and other items begin to reach customers. And in Stage 3, 5G services start to be offered (black sea). That's when we start to see applications running on 5G networks. Think about things like enormous multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my 2nd 5G forecast for 2021 is that we will start Stage 3 by this summer. This starts something of a virtuous cycle: Many people do not truly appreciate the innovation. But they will care if there are exciting applications that can just be accessed with a 5G phone.
That causes more 5G apps being established. In reality, 5G is going to open a suite of unbelievable applications: self-driving automobiles, the Internet of Things, robotic surgical treatment, and more. All of these technologies require 5G. The financial investment chances moving forward will be massive. Stepping away from 5G, the next crucial innovation I visualize in 2021 is CRISPR hereditary modifying. CRISPR means "clustered routinely interspaced brief palindromic repeat." It's a mouthful. But it's one of the most exciting developments in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not operate properly. CRISPR uses a comparable idea however with our hereditary code. "Typos" in our genome can cause illness. CRISPR can correct these "typos." For many years, CRISPR was mainly a niche technology that wasn't well comprehended. And during that time, there were actually only three business running in this space. But things are altering. CRISPR is no longer simply theoretical. We're seeing real results. We're dealing with illness and seeing that this innovation simply works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This entire industry is efficiently a greenfield chance.
There's room for many business to exist in this area. white house. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or three more hereditary modifying business will hold their IPOs. Sticking to biotechnology, we are seeing remarkable things taking place at the convergence of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, just announced at the end of 2020 that its newest Alpha, Fold software can precisely anticipate the folding of a protein based solely on its amino acid sequence with 92. 4% precision. That is very important since the way a protein in the body folds determines if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has actually been a trial-and-error procedure. And now, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much simpler to develop drugs that do what they're created to do. And here's my next forecast. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but numerous drug therapies produced using this innovation. This was one of those advancements that almost no one observed. But it's going to have profound ramifications for treating illness. And, obviously, there will be lots of investment chances in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it pulled back possibly considerably before going higher. I've been covering bitcoin for a long time now. One of the first research reports I ever released was on bitcoin - democratic republic. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anyone who followed my recommendation. But at the time of that initial recommendation, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
But nobody is asking that concern anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. jeff brown 1 biotech company. Mass, Mutual is a 150-year-old institution. So consider that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus offer forecast In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown is worth about $27. 5 million and claims the details depends on date since February 2021, but we might not independently confirm this claim. Provided Jeff Brown's past, he likely has a significant net worth, but we can't hammer down an accurate figure at this minute. Brown is best understood for his sage-like ability to choose winning technology stocks. He invested more than 25 years looking into technology business like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience offers him an exceptional viewpoint on the market. He's always on the hunt for new opportunities, and he shares a number of his finest choices in the Future Report.
That's high praise, but it's not ridiculously reasoned. Brown has an excellent credibility as a stock-picker, and he effectively anticipated a few of the biggest financial occasions of the past twenty years. Although he doesn't appear to release his choices to the general public, the service's success is a direct indicator of Brown's stock-picking expertise. Nobody on Wall Street gets it ideal every time, but Jeff Brown's precise predictions have actually made him legions of dedicated fans. That says a lot about his ability. The Near Future Report is published by Brownstone Research, a popular monetary research publisher. Brownstone Research provides a number of research study services with a wide array of specializations - toxic tech 5 tech darlings.
The business is likewise associated with Bonner & Partners, another well-respected research study publisher - social media. On its site, Brownstone states its mission is to provide retail investors with professional-grade research: "For too long, the very best financial investment research study has actually not been readily available to specific financiers. It has been usually reserved for investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown genome sequencing. The objective of Brownstone Research is to make that kind of proprietary research available to any financiers wanting to gain an edge in the markets. The objective is simple to deliver distinct and rewarding investment research study found nowhere else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research study, and he likewise functions as the firm's Chief Financial investment Expert.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to offer its clients. After years of stable success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a household name throughout the majority of America. If you understand even a little bit about the marketplace, you know that he has a credibility as a King Midas of sorts. jeff brown prediction for 2021. Everything he touches turns to gold! Jeff is well aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge task.
In reality, Brown believes S.A.V. genetic sequencing companies jeff brown. could be "the biggest trend of the 2020s, and he's not alone. Have a look at these quotes from other widely known S.A.V. bulls: Elon's next huge act will be weding two cutting-edge technologies: expert system and electrical cars. Musk hopes the mix will help him develop the first fully-autonomous, self-driving vehicles ever. It's nothing brief of the vehicle industry's Holy Grail. As you know, electrical automobiles and self-driving vehicle stocks have been big this year, however the Wall Street machine has actually been big on hype without much concrete outcome. Regardless of an extreme increase in competition over the previous few years, Brown still thinks Musk has the best possibility of putting it all together.
tech could be the magic string that ties everything together. S.A.V. stands for Shared Autonomous Vehicle, and it might be the future of transport. Essentially, this innovation would allow you to rent your vehicle as a self-governing, self-driving taxi when you're not using it. You just get out of the vehicle and press a button on an app that informs the automobile to "join the fleet." Next thing you know, you're unwinding on your couch while your car shuttles ride-sharers around town. Best of all, you get to keep a significant portion of the earnings. It sounds outrageous, however it could be closed than you believe.